These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20493044)

  • 1. Muscarinic receptor activation inhibits both release and synthesis of noradrenaline in rat hippocampal synaptosomes.
    Birch PJ; Fillenz M
    Neurochem Int; 1986; 8(2):171-7. PubMed ID: 20493044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction acetylcholine-glutamate in rat hippocampus: involvement of two subtypes of M-2 muscarinic receptors.
    Marchi M; Raiteri M
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1255-60. PubMed ID: 2564891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct muscarinic receptor subtypes differentially modulate acetylcholine release from corticocerebral synaptosomes.
    Pittel Z; Heldman E; Rubinstein R; Cohen S
    J Neurochem; 1990 Aug; 55(2):665-72. PubMed ID: 1695243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of M1 muscarinic receptors triggers transmitter release from rat sympathetic neurons through an inhibition of M-type K+ channels.
    Lechner SG; Mayer M; Boehm S
    J Physiol; 2003 Dec; 553(Pt 3):789-802. PubMed ID: 14555721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of muscarinic autoreceptors and heteroreceptors in the rat brain: effects of a novel M1 agonist, AF102B.
    Ono S; Saito Y; Ohgane N; Kawanishi G; Mizobe F
    Eur J Pharmacol; 1988 Oct; 155(1-2):77-84. PubMed ID: 3243333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3H-Noradrenaline release from mouse iris-ciliary body: role of presynaptic muscarinic heteroreceptors.
    Bernhard M; Takeda K; Keller C; Haslebacher M; Lambrou GN; Trendelenburg AU
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):305-13. PubMed ID: 15375642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic M2 muscarinic receptor-mediated inhibition of endogenous noradrenaline release from the isolated vascularly perfused rat stomach.
    Yokotani K; Osumi Y
    J Pharmacol Exp Ther; 1993 Jan; 264(1):54-60. PubMed ID: 8423550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of modulation of [(3)H]noradrenaline release from rat hippocampal synaptosomes by GABA and benzodiazepine receptors.
    Fung SC; Fillenz M
    Neurochem Int; 1985; 7(1):95-101. PubMed ID: 20492904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptors mediating inhibition of gamma-aminobutyric acid release in rat corpus striatum and their pharmacological characterization.
    Raiteri M; Marchi M; Paudice P; Pittaluga A
    J Pharmacol Exp Ther; 1990 Aug; 254(2):496-501. PubMed ID: 2384883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway.
    Drukarch B; Schepens E; Stoof JC
    Neuroscience; 1990; 37(1):1-9. PubMed ID: 1978737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the interaction between muscarinic M2 receptors and beta-adrenoceptor subtypes in guinea-pig isolated ileum.
    Reddy H; Watson N; Ford AP; Eglen RM
    Br J Pharmacol; 1995 Jan; 114(1):49-56. PubMed ID: 7712028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function.
    Marchi M; Raiteri M
    J Neurochem; 1996 Nov; 67(5):1974-81. PubMed ID: 8863503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of several muscarinic agonists on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart.
    Fozard JR; Muscholl E
    Br J Pharmacol; 1972 Aug; 45(4):616-29. PubMed ID: 5085235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic receptor agonist-mediated modulation of neuronal activity in rat cerebral cortex.
    Lin Y; Phillis JW
    Eur J Pharmacol; 1991 Jul; 200(1):45-52. PubMed ID: 1722754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release.
    Vizi ES; Kobayashi O; Töröcsik A; Kinjo M; Nagashima H; Manabe N; Goldiner PL; Potter PE; Foldes FF
    Neuroscience; 1989; 31(1):259-67. PubMed ID: 2549449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB; Reuben M
    Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic M1 and M2 receptors mediate depolarization and presynaptic inhibition in guinea-pig enteric nervous system.
    North RA; Slack BE; Surprenant A
    J Physiol; 1985 Nov; 368():435-52. PubMed ID: 4078746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.
    Raiteri M; Leardi R; Marchi M
    J Pharmacol Exp Ther; 1984 Jan; 228(1):209-14. PubMed ID: 6141277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between muscarinic receptor-mediated inhibition of adenylate cyclase and autoreceptor inhibition of [3H] acetylcholine release in rat hippocampus.
    Vickroy TW; Cadman ED
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1039-44. PubMed ID: 2557410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.